The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
The concurrent chemoradiation paradigm—general principles
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Antiangiogenic and anti-VEGF therapy in combination with radiation Angiogenesis is essential for sustained tumor growth, and many new cancer therapies are directed against modification of the tumor vasculature”
BackgroundRadiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., Raben, D., Jassem, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053422 · Cited by 5,115
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
Taxol stabilizes microtubules in mouse fibroblast cells.
Schiff, P. B., & Horwitz, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1561 · Cited by 1,970
Folkman, J. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131306 · Cited by 1,209
Tumor microenvironmental physiology and its implications for radiation oncology
Vaupel, P. (2004) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.04.008 · Cited by 947
Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity
Gordon Steel, G., & Peckham, M. J. (1979) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(79)90044-0 · Cited by 908
Fluorouracil: biochemistry and pharmacology.
Pinedo, H. M., & Peters, G. F. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.10.1653 · Cited by 834
Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer
Brizel, D. M., Wasserman, T. H., Henke, M., Strnad, V., Rudat, V., Monnier, A., Eschwege, F., Zhang, J., Russell, L., Oster, W., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.19.3339 · Cited by 828
Brown, J. M. (1999) · PubMed · Cited by 698
Repopulation of cancer cells during therapy: an important cause of treatment failure
Kim, J. J., & Tannock, I. F. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1650 · Cited by 686
Combined effects of angiostatin and ionizing radiation in antitumour therapy
Mauceri, H. J., Hanna, N. N., Beckett, M. A., Gorski, D. H., Staba, M.-J., Stellato, K. A., Bigelow, K., Heimann, R., Gately, S., Dhanabal, M., et al. (1998) · Nature · doi:10.1038/28412 · Cited by 668
Moulder, J. E., & Rockwell, S. (1984) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(84)90301-8 · Cited by 606
X-Ray Sensitivity during the Cell Generation Cycle of Cultured Chinese Hamster Cells
Sinclair, W. K., & Morton, R. A. (1966) · Radiation Research · doi:10.2307/3572025 · Cited by 547
In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.
Milas, L., Mason, K. A., Hunter, N. R., et al. (2000) · PubMed · Cited by 503
Loss of local control with prolongation in radiotherapy
Fowler, J. F., & Lindstrom, M. J. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90768-d · Cited by 489
The radioresponsiveness of human tumours and the initial slope ofthe cell survival curve
Deacon, J., Peckham, M. J., & Steel, G. G. (1984) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(84)80074-2 · Cited by 467
Changes in X-ray Sensitivity of HeLa Cells during the Division Cycle
TERASIMA, T., & TOLMACH, L. J. (1961) · Nature · doi:10.1038/1901210a0 · Cited by 442
Wachsberger, P. R., Burd, R., & Dicker, A. P. (2003) · PubMed · Cited by 395
Chinnaiyan, P., Huang, S., Vallabhaneni, G., Armstrong, E., Varambally, S., Tomlins, S. A., Chinnaiyan, A. M., & Harari, P. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3547 · Cited by 386
SR 4233 (Tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours
Brown, J. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.220 · Cited by 366
Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors.
Vokes, E. E., & Weichselbaum, R. R. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.5.911 · Cited by 364
Self-citationKoukourakis, M. I., Giatromanolaki, A., Sivridis, E., Simopoulos, C., Turley, H., Talks, K., Gatter, K. C., & Harris, A. L. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02848-1 · Cited by 361
Khodarev, N. N., Beckett, M., Labay, E., Darga, T., Roizman, B., & Weichselbaum, R. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308102100 · Cited by 326
Dent, P., Reardon, D. B., Park, J. S., Bowers, G., Logsdon, C., Valerie, K., & Schmidt-Ullrich, R. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.8.2493 · Cited by 326
Sawada, N., Ishikawa, T., Sekiguchi, F., Tanaka, Y., & Ishitsuka, H. (1999) · PubMed · Cited by 319
Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents
Hickman, M. J., & Samson, L. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10764 · Cited by 318
Enhancement of radiosensitivity by proteasome inhibition: Implications for a role of NF-κB
Russo, S. M., Tepper, J. E., Baldwin, A. S., Liu, R., Adams, J., Elliott, P., & Cusack, J. C. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01446-8 · Cited by 318
Hermisson, M., Klumpp, A., Wick, W., Wischhusen, J., Nagel, G., Roos, W., Kaina, B., & Weller, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03583.x · Cited by 311
The mechanism of action of radiosensitization of conventional chemotherapeutic agents
Lawrence, T. S., Blackstock, A. W., & McGinn, C. (2003) · Seminars in Radiation Oncology · doi:10.1053/srao.2003.50002 · Cited by 296
The epidermal growth factor receptor mediates radioresistance
Liang, K., Ang, K. K., Milas, L., Hunter, N., & Fan, Z. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00511-x · Cited by 292
Oxidative stress, redox, and the tumor microenvironment
Cook, J. A., Gius, D., Wink, D. A., Krishna, M. C., Russo, A., & Mitchell, J. B. (2004) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.04.001 · Cited by 284
Lethality induced by a single site-specific double-strand break in a dispensable yeast plasmid.
Bennett, C. B., Lewis, A. L., Baldwin, K. K., & Resnick, M. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5613 · Cited by 257
X-Ray Sensitivity and DNA Synthesis in Synchronous Populations of HeLa Cells
Terasima, T., & Tolmach, L. J. (1963) · Science · doi:10.1126/science.140.3566.490 · Cited by 248
Hypoxia in Tumors: A Paradigm for the Approach to Biochemical and Physiologic Heterogeneity
Coleman, C. N. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.5.310 · Cited by 241
Bandyopadhyay, D., Mandal, M., Adam, L., Mendelsohn, J., & Kumar, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1568 · Cited by 229
Bonner, J. A., Raisch, K. P., Trummell, H. Q., et al. (2000) · PubMed · Cited by 220
Overgaard, J., Sand Hansen, H., Andersen, A. P., Hjelm-Hansen, M., Jørgensen, K., Sandberg, E., Berthelsen, A., Hammer, R., & Pedersen, M. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90917-6 · Cited by 214
Biologic Basis for Combining Drugs With Radiation
WILSON, G., BENTZEN, S., & HARARI, P. (2006) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2005.08.001 · Cited by 198
Sasse, A. D., de Oliveira Clark, L. G., Sasse, E. C., & Clark, O. A. C. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.06.023 · Cited by 198
Crane, C. H., Abbruzzese, J. L., Evans, D. B., Wolff, R. A., Ballo, M. T., Delclos, M., Milas, L., Mason, K., Charnsangavej, C., Pisters, P. W. T., et al. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)02740-7 · Cited by 198
Taghian, A. G., Abi-Raad, R., Assaad, S. I., Casty, A., Ancukiewicz, M., Yeh, E., Molokhia, P., Attia, K., Sullivan, T., Kuter, I., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.119 · Cited by 192
Enhanced radiation damage of tumor vasculature by mTOR inhibitors
Shinohara, E. T., Cao, C., Niermann, K., Mu, Y., Zeng, F., Hallahan, D. E., & Lu, B. (2005) · Oncogene · doi:10.1038/sj.onc.1208715 · Cited by 183
Brown, J. M., & Lemmon, M. J. (1990) · PubMed · Cited by 181
Roh, H., Boucher, Y., Kalnicki, S., Buchsbaum, R., Bloomer, W. D., & Jain, R. K. (1991) · PubMed · Cited by 180
DOSE, TIME, VOLUME RELATIONSHIPS IN SQUAMOUS CELL CARCINOMA OF THE SUPRAGLOTTIC LARYNX
SHUKOVSKY, L. J. (1970) · American Journal of Roentgenology · doi:10.2214/ajr.108.1.27 · Cited by 179
Gemcitabine: A cytidine analogue active against solid tumors
Hui, Y. F., & Reitz, J. (1997) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/54.2.162 · Cited by 177
Komaki, R., Lee, J. S., Milas, L., Lee, H. K., Fossella, F. V., Herbst, R. S., Allen, P. K., Liao, Z., Stevens, C. W., Lu, C., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.10.005 · Cited by 172
West, C., Davidson, S., Roberts, S., & Hunter, R. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.531 · Cited by 167
Milosevic, M., Fyles, A., Hedley, D., & Hill, R. (2004) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.04.006 · Cited by 163
Plasma and Cerebrospinal Fluid Pharmacokinetics of Intravenous Temozolomide in Non-human Primates
Patel, M. C., McCully, C. L., Godwin, K. S., & Balis, F. M. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1022592913323 · Cited by 154
Stiff, P. J., Emmanouilides, C. E., Bensinger, W., Gentile, T., Blazar, B. R., Shea, T. C., Lu, J., Isitt, J. J., Cesano, A., & Spielberger, R. T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8340 · Cited by 147
Survival of human glioma cells treated with various combination of temozolomide and X-rays
Rijn, J. V., Heimans, J. J., van den Berg, J., van der Valk, P., & Slotman, B. J. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00539-8 · Cited by 145
In vitro evaluation of temozolomide combined with X-irradiation
Wedge, S. R., Porteous, J. K., Glaser, M. G., Marcus, K., & Newlands, E. S. (1997) · Anti-Cancer Drugs · doi:10.1097/00001813-199701000-00013 · Cited by 145
Combined-Modality Treatment of Solid Tumors Using Radiotherapy and Molecular Targeted Agents
Ma, B. B. Y., Bristow, R. G., Kim, J., & Siu, L. L. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.044 · Cited by 130
Evaluating Response to Antineoplastic Drug Combinations in Tissue Culture Models
Reynolds, C. P., & Maurer, B. J. (2005) · Humana Press eBooks · doi:10.1385/1-59259-869-2:173 · Cited by 126
Cisplatin and radiation: Interaction probabilities and therapeutic possibilities
Begg, A. C. (1990) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(90)90226-a · Cited by 124
Roos, W. P., Baumgärtner, M., & Kaina, B. (2004) · Oncogene · doi:10.1038/sj.onc.1207080 · Cited by 123
Targeting the c-Met Pathway Potentiates Glioblastoma Responses to γ-Radiation
Lal, B., Xia, S., Abounader, R., & Laterra, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0166 · Cited by 120
Dey, S., Spring, P. M., Arnold, S. M., Valentino, J. P., Damodaran, C., Regine, W. F., Mohiuddin, M., & Ahmed, M. M. (2003) · PubMed · Cited by 120
Ning, S., Laird, D., Cherrington, J. M., & Knox, S. J. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)157[0045:taasas]2.0.co;2 · Cited by 119
Biological basis for chemo-radiotherapy interactions
Hennequin, C., & Favaudon, V. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00360-4 · Cited by 117
Murata, R., Nishimura, Y., & Hiraoka, M. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00628-1 · Cited by 112
Rosen, L. S., Abdi, E. A., Davis, I. D., Gutheil, J. C., Schnell, F. M., Zalcberg, J. R., Cesano, A., Gayko, U., Chen, M.-G., & Clarke, S. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.1152 · Cited by 110
Molecular mechanisms of radiation-induced accelerated repopulation
Schmidt‐Ullrich, R., Contessa, J. N., Dent, P., Mikkelsen, R. B., Valerie, K. C., Reardon, D. B., Bowers, G. D., & Lin, P. (1999) · Radiation Oncology Investigations · doi:10.1002/(sici)1520-6823(1999)7:6 · Cited by 110
Wick, W., Wick, A., Schulz, J. B., DICHGANS, J., Rodemann, H. P., & Weller, M. (2002) · PubMed · Cited by 110
S-phase specificity of cell killing by docetaxel (Taxotere) in synchronised HeLa cells
Hennequin, C., Giocanti, N., & Favaudon, V. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.232 · Cited by 108
Targeting Signal Transduction Pathways in Colorectal Cancer—More Than Skin Deep
Cohen, S. J., Cohen, R. B., & Meropol, N. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.194 · Cited by 92
Therapeutic Advantage of Hypoxic Cells in Tumors: A Theoretical Study
Brown, J. M., & Koong, A. C. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.3.178 · Cited by 91
Sugiyama, K., Shimizu, M., Akiyama, T., Tamaoki, T., Yamaguchi, K., Takahashi, R., Eastman, A. R., & Akinaga, S. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000301)85:5<703::aid-ijc17>3.0.co;2-7 · Cited by 89
Krause, M., Ostermann, G., Petersen, C., Yaromina, A., Hessel, F., Harstrick, A., van der Kogel, A. J., Thames, H. D., & Baumann, M. A. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.06.032 · Cited by 88
Aebersold, D. M., Kollár, A., Beer, K. T., Laissue, J. A., Greiner, R. H., & Djonov, V. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010220)96:1<41::aid-ijc5>3.0.co;2-f · Cited by 87
Heinrich, M. C., Hoatlin, M. E., Zigler, A. J., Silvey, K. V., Bakke, A. C., Keeble, W. W., Zhi, Y., Reifsteck, C. A., Grompe, M., Brown, M. G., et al. (1998) · Blood · doi:10.1182/blood.v91.1.275 · Cited by 80
Rationale for chemoradiotherapy
Nishimura, Y. (2004) · International Journal of Clinical Oncology · doi:10.1007/s10147-004-0443-z · Cited by 71
Fluoropyrimidine-radiation interactions in cells and tumors
Lawrence, T. S., Tepper, J. E., & Blackstock, A. W. (1997) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(97)80024-0 · Cited by 61
Tumor Reoxygenation as a Mechanism of Taxol-Induced Enhancement of Tumor Radioresponse
Milas, L., Hunter, N. R., Mason, K. A., Milross, C., & Peters, L. J. (1995) · Acta Oncologica · doi:10.3109/02841869509093999 · Cited by 56
Antitumor interaction of short-course endostatin and ionizing radiation.
Hanna, N. N., Seetharam, S., Mauceri, H. J., Beckett, M. A., Jaskowiak, N. T., Salloum, R. M., Hari, D. M., Dhanabal, M., Ramchandran, R., Kalluri, R., et al. (2000) · PubMed · Cited by 56
Yang, L.-X., Douple, E. B., O’Hara, J. A., & Wang, H.-J. (1995) · Radiation Research · doi:10.2307/3579218 · Cited by 54
Epidermal growth factor receptor and signal transduction: potential targets for anti-cancer therapy
Pal, S. K., & Pegram, M. D. (2005) · Anti-Cancer Drugs · doi:10.1097/00001813-200506000-00003 · Cited by 52
A New Nonlinear Mixture Response Surface Paradigm for the Study of Synergism: A Three Drug Example
White, D. B., Slocum, H. K., Brun, Y. F., Wrzosek, C., & Greco, W. R. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489316 · Cited by 48
Tumor hypoxia and anemia: Impact on the efficacy of radiation therapy
Kumar, P. (2000) · Seminars in Hematology · doi:10.1016/s0037-1963(00)90061-1 · Cited by 43
Richmond, R. C. (1984) · Radiation Research · doi:10.2307/3576334 · Cited by 41
Wouters, B. G., Wang, L.-H., & Brown, J. M. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_5.s29 · Cited by 37
Subadditive interaction of radiation and taxol in vitro
Ingram, M. L., & Redpath, J. L. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00629-3 · Cited by 30
Mitochondrial dysfunction after aerobic exposure to the hypoxic cytotoxin tirapazamine.
Wouters, B. G., Delahoussaye, Y. M., Evans, J., Birrell, G. W., Dorie, M. J., Wang, J., MacDermed, D. M., Chiu, R. K., & Brown, J. M. (2001) · PubMed · Cited by 29
Lartigau, E. F., & Guichard, M. (1995) · International Journal of Radiation Biology · doi:10.1080/09553009514550261 · Cited by 22
Dittmann, K., Gueven, N., Mayer, C., & Rodemann, H. P. (2001) · Protein Engineering Design and Selection · doi:10.1093/protein/14.3.157 · Cited by 20
Cited by
Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements
Her, S., Jaffray, D. A., & Allen, C. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.012 · Cited by 865
Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy
Song, G., Cheng, L., Chao, Y., Yang, K., & Liu, Z. (2017) · Advanced Materials · doi:10.1002/adma.201700996 · Cited by 771
Lu, K., He, C., Guo, N., Chan, C., Ni, K., Lan, G., Tang, H., Pelizzari, C., Fu, Y.-X., Spiotto, M. T., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0203-4 · Cited by 596
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
Cardoso, F., Costa, A., Norton, L., Senkus, E., Aapro, M., André, F., Barrios, C. H., Bergh, J., Biganzoli, L., Blackwell, K. L., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu385 · Cited by 540
Chemoradiotherapy in Malignant Glioma: Standard of Care and Future Directions
Stupp, R., Hegi, M. E., Gilbert, M. R., & Chakravarti, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8554 · Cited by 529
Metadata
- Authors
- Seiwert, T. Y., Salama, J. K., & Vokes, E. E.
- Venue
- Nature Clinical Practice Oncology
- Published
- 2007-02
- Volume
- 4
- Issue
- 2
- Pages
- 86-100
- ISSN
- 1743-4254 (ISSN-L)
- 1743-4262
- OpenAlex
- W2351274769
- Cited by
- 443
- References
- 90
- FWCI
- 15.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.